PeterPhoto/iStock Unreleased via Getty Images Despite a big bid from GameStop Corp. ( GME ), eBay, Inc. ( EBAY ) didn't soar on the announcement over the weekend. The market wasn't overly impressed by the proposal for the combination with a struggling retailer. My investment thesis remains bullish on the stock, though the merger proposal isn't overly enticing. Finviz GameStop Proposal GameStop sub...
PeterPhoto/iStock Unreleased via Getty Images Despite a big bid from GameStop Corp. ( GME ), eBay, Inc. ( EBAY ) didn't soar on the announcement over the weekend. The market wasn't overly impressed by the proposal for the combination with a struggling retailer. My investment thesis remains bullish on the stock, though the merger proposal isn't overly enticing. Finviz GameStop Proposal GameStop submitted a non-binding proposal to acquire eBay for $125 per share. The stock entered the week trading at $100 due in part to GameStop accumulating a large position and the market rumors of a potential bid. The proposal values eBay at $55.5 billion, with the offer comprising 50% cash and 50% GameStop common stock. Naturally, the acquirer wants to go back and claim the offer is a sizable 36% premium to the 90-day VWAP and 46% above the unaffected close, but one has to really question how much a 5% position obtained at least partially through derivatives pushed eBay higher. The immediate problem is the size of the companies involved in the merger. GameStop has a market cap of ~$11 billion, while eBay is valued at $56 billion via this offer. The gaming company has to take on substantial debt to complete the deal and massively dilute existing shareholders. While eBay shareholders only cash out 50% of their investment, with the remaining amount in stock. GameStop CEO Ryan Cohen went on CNBC to discuss the merger, and he likely provided eBay shareholders with no confidence in how the merger closes. The company claims a letter from TD Securities for up to $20 billion in financing, but eBay needs far more than a letter. The company has a cash balance of ~$9.4 billion, but GameStop also has $4.2 billion in debt. The retailer can finally put that cash to work, but the debt load ends up at a sizable $23 billion. Outside of the financing questions, Ryan Cohen didn't go to great lengths to explain the rationale for the merger. The primary focus appears to be $2 billion in annualized cost ...
Facebook and Instagram have a new way to detect and remove users under 13: AI bone structure analysis. In a blog post on Tuesday , Meta - Facebook and Instagram's parent company - says its AI system will scan photos and videos posted to its platforms for "general themes and visual cues," including height and bone structure. "We want to be clear: this is not facial recognition," Meta says in the bl...
Facebook and Instagram have a new way to detect and remove users under 13: AI bone structure analysis. In a blog post on Tuesday , Meta - Facebook and Instagram's parent company - says its AI system will scan photos and videos posted to its platforms for "general themes and visual cues," including height and bone structure. "We want to be clear: this is not facial recognition," Meta says in the blog post, adding that it "does not identify the specific person in the image." This system is part of Meta's efforts to keep kids under 13 off its platforms, and will also analyze posts, comments, bios, and captions to search for "contextual clues" t … Read the full story at The Verge.
Meta Platforms is expanding AI-powered age verification and teen protections across Instagram and Facebook, but the impact on growth is likely to differ sharply from Roblox’s recent slowdown.
Meta Platforms is expanding AI-powered age verification and teen protections across Instagram and Facebook, but the impact on growth is likely to differ sharply from Roblox’s recent slowdown.
Seeking Alpha More on Pfizer Pfizer: Why You Should Double Down Into Q1 Pfizer Could Surprise Again This Earnings Season (Preview) Pfizer: Painful Recovery Underway Pfizer beats Q1 street views Pfizer Q1 preview: Analysts bullish on robust pipeline; comments on obesity pipeline, guidance in focus
Seeking Alpha More on Pfizer Pfizer: Why You Should Double Down Into Q1 Pfizer Could Surprise Again This Earnings Season (Preview) Pfizer: Painful Recovery Underway Pfizer beats Q1 street views Pfizer Q1 preview: Analysts bullish on robust pipeline; comments on obesity pipeline, guidance in focus
Ferrari press release ( RACE ): Q1 Non-GAAP EPS of €2.33 misses by €0.04. Revenue of €1.85B (+3.4% Y/Y) beats by €20M. EBITDA of Euro 722 million, with EBITDA margin of 39.1%, up 4% versus prior year (up 9% at constant currency). Industrial free cash flow of Euro 653 million, up 5% versus the prior year. Our guidance is based on current visibility on the Middle East crisis effects, that we keep on...
Ferrari press release ( RACE ): Q1 Non-GAAP EPS of €2.33 misses by €0.04. Revenue of €1.85B (+3.4% Y/Y) beats by €20M. EBITDA of Euro 722 million, with EBITDA margin of 39.1%, up 4% versus prior year (up 9% at constant currency). Industrial free cash flow of Euro 653 million, up 5% versus the prior year. Our guidance is based on current visibility on the Middle East crisis effects, that we keep on managing actively. (€B, unless otherwise stated) 2026GUIDANCE 2025 NET REVENUES ~7.50 7.15 ADJ. EBITDA (margin %) ≥2.93≥39.0% 2.7738.8% ADJ. OPERATING PROFIT (margin %) ≥2.22≥29.5% 2.1129.5% ADJ. DILUTED EPS (€) ≥9.45 (8) 8.96 ( 8 ) INDUSTRIAL FCF ≥1.50 1.54 Click to enlarge More on Ferrari Ferrari: Why 'Luxuryflation' Is Still Eroding The Bull Case Ferrari: The Luxury Flywheel Seems Intact, But 'Luce' Is The Brand Test Of The Decade Ferrari Remains Resilient But Isn't A Buy Yet Ferrari Q1 2026 Earnings Preview European auto stocks in focus after Trump tariff move; Continental, Mercedes-Benz, and Volkswagen slip
Carolina Rudah/iStock via Getty Images Introduction Novo Nordisk ( NVO ) has been picking up steam since I last rated it a strong buy , as it has gained 18.18% since, vastly outpacing the S&P 500's 7.65% return. With some momentum finally going Novo's way and the upcoming earnings, I want to dive into why I believe Novo is still one of the best opportunities on the market and probably in healthcar...
Carolina Rudah/iStock via Getty Images Introduction Novo Nordisk ( NVO ) has been picking up steam since I last rated it a strong buy , as it has gained 18.18% since, vastly outpacing the S&P 500's 7.65% return. With some momentum finally going Novo's way and the upcoming earnings, I want to dive into why I believe Novo is still one of the best opportunities on the market and probably in healthcare. Current Dynamics First, I'll dive into the major milestones since I last reviewed Novo Nordisk, as there have been a lot of developments since. First, the FDA approved both Wegovy HD and Awiqli in late March. Wegovy HD was approved in just 54 days under a National Priority Voucher, and the STEP UP trial showed a mean weight loss of 20.7% over 72 weeks, putting Wegovy HD on a competitive footing with tirzepatide on efficacy. On the Awiqli side, this is the first once-weekly basal insulin for adults with type 2 diabetes, which is a real franchise extension in a category that needed one. However, Novo has been facing a wave of patent expiration of its core semaglutide products in international markets as they expired in China, India, South Africa, and Brazil. Looking at China, the expiration of the foundational patent has opened a vast commercial opportunity for domestic generic manufacturers, given the country's 148MM adults living with diabetes. At least 16 Chinese firms are already in various stages of developing generic semaglutide . Similarly, in India, cheap generics had already risen to 33% of the GLP-1 segment by March 2026, with prices as low as $14 per month. Though a surprising twist came with the OpenAI strategic partnership , which is effectively an operational transformation. See, the Volume-over-Price era requires unprecedented operational efficiency, and that's why Novo entered into a deal with OpenAI ( OPENAI ), with this collaboration aiming to integrate advanced AI across the company's research, manufacturing, and commercial operations. Pilot programs are...
Haverty Furniture press release ( HVT ): Q1 GAAP EPS of $0.26. Revenue of $189.1M (+4.1% Y/Y) Consolidated sales increased 4.1% to $189.1 million. Comparable store sales increased 4.3%. Gross profit margin was 61.5% compared to 61.2%. More on Haverty Furniture Haverty Furniture Sees Margin-Accretive Growth And Durability In A Challenging Market Haverty Furniture: Idiosyncratic, Cash Yield Income P...
Haverty Furniture press release ( HVT ): Q1 GAAP EPS of $0.26. Revenue of $189.1M (+4.1% Y/Y) Consolidated sales increased 4.1% to $189.1 million. Comparable store sales increased 4.3%. Gross profit margin was 61.5% compared to 61.2%. More on Haverty Furniture Haverty Furniture Sees Margin-Accretive Growth And Durability In A Challenging Market Haverty Furniture: Idiosyncratic, Cash Yield Income Play But Not Best-In-Class Value Haverty Furniture Companies, Inc. (HVT) Presents at UBS Global Consumer and Retail Conference - Slideshow Haverty Furniture Q1 2026 Earnings Preview Haverty projects 2026 CapEx of $33.5M while entering Pennsylvania and expanding store network
In this article PFE Follow your favorite stocks CREATE FREE ACCOUNT Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products show growth. Here's what the company reported ...
In this article PFE Follow your favorite stocks CREATE FREE ACCOUNT Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products show growth. Here's what the company reported for the first quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per share: 75 cents adjusted vs. 72 cents expected Revenue: $14.45 billion vs. $13.79 billion expected The pharmaceutical giant is looking to longer-term investments in its pipeline, including its recent $10 billion acquisition of the obesity biotech Metsera , to counter waning Covid product sales and declines from older drugs. Pfizer is focused on several crucial data releases this year, including late-stage trial results on an experimental targeted drug in lung cancer. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Dell Board Unanimously Backs Redomiciliation To Texas As Delaware Exodus Accelerates Dell Technologies' Board of Directors unanimously approved a proposal to move the company's state of incorporation from Delaware to Texas. This adds to the growing trend of redomiciliation, with companies such as Tesla, SpaceX, Neuralink, Coinbase , Affirm, TripAdvisor, eXp World Holdings, and others moving from D...
Dell Board Unanimously Backs Redomiciliation To Texas As Delaware Exodus Accelerates Dell Technologies' Board of Directors unanimously approved a proposal to move the company's state of incorporation from Delaware to Texas. This adds to the growing trend of redomiciliation, with companies such as Tesla, SpaceX, Neuralink, Coinbase , Affirm, TripAdvisor, eXp World Holdings, and others moving from Delaware to business-friendly states. Shareholders will vote on the redomiciliation at Dell's upcoming 2026 annual meeting on June 25. "The proposed redomestication would align Dell Technologies' state of incorporation with its roots and long-standing center of operations," the company wrote in a press release. Dell said the move would align its legal home with its corporate origin story: Michael Dell founded the company in Austin in 1984, and today Dell's headquarters, CEO, and largest concentration of U.S. employees are all based in Texas. "From my dorm room at the University of Texas in 1984 to our headquarters today in Round Rock, Texas, has given Dell what every great company needs to grow — extraordinary talent, world-class research universities, and a business environment that lets us build for the long term," said Dell CEO Michael Dell. "Texas is where Dell has innovated, expanded, and invested for more than four decades, and bringing our legal home to Texas reflects what we've been building here all along." If shareholders approve the move, the company plans to opt into Texas provisions that would require investors to own at least 3% of shares or $1 million of stock, whichever is lower, to submit shareholder proposals. A separate Texas rule would require shareholders to hold a 3% ownership stake to bring derivative lawsuits against management. The exodus from Delaware all began when a left-wing Delaware judge challenged Elon Musk over his Tesla compensation package. Delaware Court of Chancery's January 2024 decision voiding Musk's roughly $56 billion 2018 pay packag...
Supersmario/iStock via Getty Images Introduction While investors chase NVIDIA and cloud computing providers, a Pennsylvania-based battery maker is supplying the power infrastructure that keeps AI data centers running during outages. The market has not given EnerSys ( ENS ) the attention its data center exposure deserves. The market is yet to recognize EnerSys as data center infrastructure. Maybe t...
Supersmario/iStock via Getty Images Introduction While investors chase NVIDIA and cloud computing providers, a Pennsylvania-based battery maker is supplying the power infrastructure that keeps AI data centers running during outages. The market has not given EnerSys ( ENS ) the attention its data center exposure deserves. The market is yet to recognize EnerSys as data center infrastructure. Maybe that's why the stock trades at 20x earnings, like an industrial company with no growth story ahead. This takes the company to the boring corner of the market. My Strong Buy thesis has three aspects:- First, their sales grew by 28% year-on-year in the recent quarter, and management called this "the early stages of a multiyear growth cycle" on the earnings call. Second, EnerSys holds over 50% of the U.S. market share in lead-acid batteries, and every big data center built today requires EnerSys's products, like batteries, to operate. Third, an internal cost program is driving EPS growth of 50% on revenue growth of just 1%—this type of operating leverage is what someday definitely forces rating agencies to upgrade the rating of the company. Q4 FY2026 earnings drop May 20. Three weeks from now. I think it's better to be positioned before that. Recent Financials: Earnings Grew Faster Than Revenue Revenue is flat. That's true; nobody argues that. Q3 FY2026 net sales stood at $919 million , up by 1.4% year-over-year. That headline number is what most investors see and then stop reading. But that's not where the story ends; we have to look further. ENS Q3 FY26 Earnings Presentation To understand, let's dig a level deeper, and the real story unfolds. Adjusted EPS excluding the IRC 45X tax credit was reported at $1.84 for that quarter, up 50% from the last year. That shows fifty percent earnings growth on one percent revenue growth. That is what pricing discipline and cost control actually look like in financial statements. This is a margin expansion story worth noting. If we break do...
Fahad Ansari says it was ‘chilling’ that police ‘equated him with his client’ after he was stopped on return from family holiday in Ireland A lawyer who filed Hamas’s challenge to proscription in the UK was recorded by police as being a member of the banned group, “equating him with his client”. On a risk assessment form, a detective inspector, who authorised the detention of Fahad Ansari under th...
Fahad Ansari says it was ‘chilling’ that police ‘equated him with his client’ after he was stopped on return from family holiday in Ireland A lawyer who filed Hamas’s challenge to proscription in the UK was recorded by police as being a member of the banned group, “equating him with his client”. On a risk assessment form, a detective inspector, who authorised the detention of Fahad Ansari under the Terrorism Act on his return from a family holiday in Ireland, wrote “Hamas” in the space reserved for “membership of a known group”. Continue reading...
pjohnson1 Anheuser-Busch InBev ( BUD ) soared in Tuesday morning trading after topping estimates with its Q1 earnings report. Revenue was up 12.0% during the quarter to $15.3B as beer volume improved by 1.2% during the quarter, with record high first quarter volume in Mexico, Colombia, Brazil, South Africa, and Peru. In the U.S., sales to retailers grew, and the company continued to outperform the...
pjohnson1 Anheuser-Busch InBev ( BUD ) soared in Tuesday morning trading after topping estimates with its Q1 earnings report. Revenue was up 12.0% during the quarter to $15.3B as beer volume improved by 1.2% during the quarter, with record high first quarter volume in Mexico, Colombia, Brazil, South Africa, and Peru. In the U.S., sales to retailers grew, and the company continued to outperform the industry to snap up market share, with Michelob Ultra and Busch Light the top volume gainers in the industry. The company's above core beer portfolio delivered an 11% revenue increase. Performance was driven by Corona, Stella Artois, and Michelob Ultra, which delivered revenue growth of 16%, 14%, and 39%, respectively, outside their home markets. Corona successfully activated the Milano Cortina Winter Olympics and increased volume by double digits in 32 markets. EBITDA increased by 5.3% with flattish margins as disciplined overhead management enabled increased sales and marketing investments and offset transactional FX headwinds. Q1 non-GAAP EPS of $0.97 beat the consensus estimate by $0.06 and was ahead of last year's mark of $0.81. "We are encouraged by our performance in the first quarter, and, looking ahead, we are well positioned to activate the category in some of the biggest moments of celebration of the year, including the FIFA World Cup. Our consistent performance and the strength of the beer category reinforce our confidence in our ability to deliver our FY26 outlook and create a future with more cheers." Shares of Anheuser-Busch InBev ( BUD ) were up 7.8% in premarket trading to $79.66. The 52-week high for the stock is $81.56. More on Anheuser-Busch InBev Anheuser-Busch: Recent Rally Justifiable, Valuation And Growth Prospects Hinder Further Upside Anheuser-Busch InBev: Successful Premiumization And Diversification Efforts - Overbought Rally Warrants Caution Anheuser-Busch InBev SA/NV (BUD) Q4 2025 Earnings Call Transcript Anheuser-Busch InBev beats top-line an...
KKR & Co. press release ( KKR ): Q1 Non-GAAP EPS of $1.39 beats by $0.13 . Assets Under Management (“AUM”) of $758 billion, up 14% year-over-year Fee Paying Assets Under Management (“FPAUM”) of $615 billion, up 17% year-over-year Shares +1% PM. More on KKR & Co. KKR Round Two: Poised To Grow Earnings At A Double-Digit Rate KKR: A Compounding Machine Hidden Behind Private Markets Complexity KKR & C...
KKR & Co. press release ( KKR ): Q1 Non-GAAP EPS of $1.39 beats by $0.13 . Assets Under Management (“AUM”) of $758 billion, up 14% year-over-year Fee Paying Assets Under Management (“FPAUM”) of $615 billion, up 17% year-over-year Shares +1% PM. More on KKR & Co. KKR Round Two: Poised To Grow Earnings At A Double-Digit Rate KKR: A Compounding Machine Hidden Behind Private Markets Complexity KKR & Co. Inc. (KKR) Shareholder/Analyst Call - Slideshow KKR & Co. Q1 2026 Earnings Preview KKR bags over $10B financing for AI infrastructure developer launch - report